Literature DB >> 15020150

A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease.

Isaac C Yue1, Jason Poff, María E Cortés, Ruben D Sinisterra, Caroline B Faris, Patrice Hildgen, Robert Langer, V Prasad Shastri.   

Abstract

An implantable, anti-microbial delivery device for the treatment of periodontal disease has been developed. In this polymer-based delivery system, the encapsulation efficiency, release characteristics, and bioactivity of anti-microbial agent were controlled by the complexation of the drug with cyclodextrins of differing lipophilicity. Microparticles of poly(dl-lactic-co-glycolic acid) (PLGA) containing chlorhexidine (Chx) free base, chlorhexidine digluconate (Chx-Dg) and their association or inclusion complex with methylated-beta-cyclodextrin (MBCD) and hydroxypropyl-beta-cyclodextrin (HPBCD) were prepared by single emulsion, solvent evaporation technique. It was observed that encapsulation efficiency and release of the chlorhexidine derivatives from the microparticles was a function of the lipophilicity of the cyclodextrin. Complexation of the poorly water soluble Chx with the more hydrophilic HPBCD resulted in 62% higher encapsulation efficiency and longer duration of sustained release over a 2-week period than complexation with the more lipophilic MBCD. In contrast, the complexation of the more water-soluble derivative of chlorhexidine, Chx-Dg, with the more lipophilic MBCD improved encapsulation efficiency by 12% and prolonged its release in comparison to both the free Chx-Dg and its complex with HPBCD. Furthermore, it was observed that the initial burst effect could be diminished by complexation with CD. Preliminary studies have shown that the chlorhexidine released from PLGA chips is biologically active against bacterial population that is relevant in periodontitis (P. gingivalis and B. forsythus) and a healthy inhibition zone is maintained in agar plate assay over a period of at least a 1-week. The PLGA/CD delivery system described in this paper may prove useful for the localized delivery of chlorhexidine salts and other anti-microbial agents in the treatment of periodontal disease where prolonged-controlled delivery is desired.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15020150     DOI: 10.1016/j.biomaterials.2003.09.113

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  21 in total

1.  Study of release speeds and bacteria inhibiting capabilities of drug delivery membranes fabricated via electrospinning by observing bacteria growth curves.

Authors:  Yao Nan Lin; Kai Ming Chang; Shiang Cheng Jeng; Ping Yu Lin; Ray Quen Hsu
Journal:  J Mater Sci Mater Med       Date:  2011-02-03       Impact factor: 3.896

2.  A mini-review on novel intraperiodontal pocket drug delivery materials for the treatment of periodontal diseases.

Authors:  H Hau; R Rohanizadeh; M Ghadiri; W Chrzanowski
Journal:  Drug Deliv Transl Res       Date:  2014-06       Impact factor: 4.617

3.  Preparation of particulate polymeric therapeutics for medical applications.

Authors:  Jia Zhuang; Ronnie H Fang; Liangfang Zhang
Journal:  Small Methods       Date:  2017-07-25

4.  Controlled release of chlorhexidine from UDMA-TEGDMA resin.

Authors:  K J Anusavice; N-Z Zhang; C Shen
Journal:  J Dent Res       Date:  2006-10       Impact factor: 6.116

5.  Fluoride and chlorhexidine release from filled resins.

Authors:  C Shen; N-Z Zhang; K J Anusavice
Journal:  J Dent Res       Date:  2010-06-25       Impact factor: 6.116

6.  Effect of dentin etching and chlorhexidine application on metalloproteinase-mediated collagen degradation.

Authors:  Raquel Osorio; Mónica Yamauti; Estrella Osorio; María E Ruiz-Requena; David Pashley; Franklin Tay; Manuel Toledano
Journal:  Eur J Oral Sci       Date:  2011-02       Impact factor: 2.612

7.  Concurrent release of admixed antimicrobials and salicylic acid from salicylate-based poly(anhydride-esters).

Authors:  Michelle L Johnson; Kathryn E Uhrich
Journal:  J Biomed Mater Res A       Date:  2009-12       Impact factor: 4.396

8.  Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.

Authors:  Kashappa Goud H Desai; Susan R Mallery; Steven P Schwendeman
Journal:  Eur J Pharm Biopharm       Date:  2008-03-20       Impact factor: 5.571

9.  In vitro drug release study of methacrylate polymer blend system: effect of polymer blend composition, drug loading and solubilizing surfactants on drug release.

Authors:  Jun Li; David Barrow; Holly Howell; Sid Kalachandra
Journal:  J Mater Sci Mater Med       Date:  2009-10-24       Impact factor: 3.896

10.  EVA copolymer matrix for intra-oral delivery of antimicrobial and antiviral agents.

Authors:  A Ramadevi; T Padmavathy; G Stigall; D Paquette; S Kalachandra
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.